Ben Kiefel
bioscience
Chemical Computing Group
Australia
Biography
After completing his Ph.D. studies on the evolution on mitochondrial division systems, Ben co-founded Alchemy Biosciences with Matt Beasley. Within Alchemy Ben managed the development of the Acquire DNA cloning kit, which is now available internationally. Ben has subsequently co-founded affinity bio to develop ReD (Retained Display), an ultra-fast antibody display platform capable of 4-day antibody discovery.
Research Interest
antibodies discovery.
